Choose Location

We provide care in three easily-accessible locations across the Rio Grande Valley.

Weslaco

1604 East 8th St., Suite A
Weslaco, TX
Phone: (956) 447-5557

McAllen

5300 North McColl Rd., Suite 100
McAllen, TX
Phone: (956) 630-1000

Mission

1022 E. Griffin Pkwy.
Mission, TX 78572
Phone: (956) 833-6000

Blog

Lung Cancer Screening: Who Should Get a Low-Dose CT Scan?

Lung cancer can develop without causing noticeable symptoms in its early stages. By the time a persistent cough, chest discomfort, or unexplained shortness of breath appears, the disease may have already progressed. This is one reason lung cancer screening plays an important role in preventive healthcare for people at increased risk.

Low-dose computed tomography (LDCT) is a screening method that can identify certain lung abnormalities before symptoms develop. However, screening is not recommended for everyone. Eligibility depends on factors such as age, smoking history, and overall health.

November is Lung Cancer Awareness Month, providing an opportunity to better understand who may benefit from screening, how the process works, and why discussing individual risk factors with a healthcare professional matters.

What Is Lung Cancer Screening?

Lung cancer screening is a preventive medical examination designed to detect possible signs of lung cancer in people who do not currently have symptoms.

Unlike diagnostic testing, which investigates an existing health concern, screening is intended to identify abnormalities before a person notices that something is wrong.

The recommended screening method for eligible high-risk adults is low-dose computed tomography, commonly called a low-dose CT scan.

This imaging test uses X-rays and computer technology to produce detailed pictures of the lungs. It can identify small nodules or other abnormalities that may not be visible on a standard chest X-ray.

Finding a suspicious abnormality does not automatically mean someone has lung cancer. Additional evaluation may be needed to determine whether the finding requires monitoring or further testing.

Who Qualifies for Lung Cancer Screening?

Not everyone needs annual lung cancer screening. Current recommendations from the U.S. Preventive Services Task Force focus on adults who meet specific age and smoking-history criteria.

Under these recommendations, annual low-dose CT screening is advised for adults who:

  • Are between 50 and 80 years old.
  • Have a smoking history of at least 20 pack-years.
  • Currently smoke or stopped smoking within the past 15 years.

A pack-year is a measurement used to estimate lifetime cigarette exposure. Smoking one pack of cigarettes per day for 20 years equals 20 pack-years. Smoking two packs per day for 10 years also equals 20 pack-years.

Screening decisions should be made with a healthcare professional who can evaluate the patient’s medical history, potential benefits, and possible risks.

Different professional organizations may use somewhat different eligibility criteria, and insurance coverage requirements can vary.

Why Smoking History Matters

Cigarette smoking is the leading risk factor for lung cancer. Tobacco smoke contains substances that can damage cells within the lungs, increasing the likelihood that abnormal cells may develop over time.

The risk of lung cancer generally increases with the amount and duration of smoking exposure.

Although quitting smoking reduces the risk of developing lung cancer, former smokers may remain at increased risk for years after stopping.

This is why screening recommendations consider both current and former smoking history.

Importantly, lung cancer can also develop in people who have never smoked. Exposure to radon, secondhand smoke, certain workplace substances, air pollution, and other factors can contribute to risk. However, these factors alone do not necessarily qualify someone for routine screening under current USPSTF recommendations.

Patients concerned about their individual risk should discuss their history with a healthcare provider.

What Happens During a Low-Dose CT Scan?

A low-dose CT scan is generally a quick, noninvasive imaging procedure.

During the examination, the patient lies on a table that moves through a CT scanner. The machine takes detailed images of the lungs while the patient remains still and may briefly hold their breath.

Unlike some diagnostic CT examinations, routine low-dose CT lung cancer screening typically does not require intravenous contrast dye.

The scan itself usually takes only a few minutes and does not involve surgery or an incision.

Low-dose CT uses less radiation than a conventional diagnostic chest CT scan, although it still involves some radiation exposure.

Once the images are reviewed by a radiologist, the results are provided to the referring healthcare professional, who can explain any findings and recommend appropriate follow-up.

What Can a Lung Cancer Screening Detect?

Low-dose CT screening can identify lung nodules, which are small areas of abnormal tissue within the lungs.

Many lung nodules are benign and may be related to previous infections, inflammation, or other noncancerous conditions.

However, certain characteristics, including a nodule’s size, shape, appearance, and changes over time, may raise concern and require additional evaluation.

Depending on the findings, a physician may recommend another CT scan after a specified interval, additional imaging, or further diagnostic testing.

A screening result should always be interpreted within the context of the patient’s medical history and individual risk factors.

Why Early Detection Can Make a Difference

Lung cancer is often more difficult to treat when it is discovered at an advanced stage.

Screening aims to identify certain cancers earlier, when treatment may be more effective and additional options may be available.

Research has shown that low-dose CT screening can reduce lung cancer mortality among appropriately selected high-risk populations.

However, screening does not prevent lung cancer, and it cannot identify every case.

The benefit comes from combining appropriate screening eligibility, consistent follow-up, and timely evaluation of suspicious findings.

Understanding the Benefits and Limitations of Screening

Although lung cancer screening can provide important benefits, it also has limitations that patients should understand before proceeding.

One consideration is the possibility of a false-positive result. This occurs when imaging identifies an abnormality that appears suspicious but is ultimately not cancer.

Such findings may lead to additional imaging, follow-up appointments, or occasionally invasive procedures.

Screening can also identify slow-growing cancers that might never have caused symptoms during a person’s lifetime, a situation known as overdiagnosis.

Repeated annual CT examinations involve cumulative radiation exposure, although each screening scan uses a relatively low dose.

These considerations make shared decision-making important. A healthcare professional can help determine whether the potential benefits of screening outweigh the risks for an individual patient.

When Should Lung Cancer Screening Stop?

Screening is not necessarily intended to continue indefinitely.

Under USPSTF recommendations, annual screening should stop when a patient reaches age 81, has not smoked for 15 years, or develops a health condition that substantially limits life expectancy or the ability or willingness to undergo curative lung surgery.

These recommendations recognize that screening is most beneficial when a person is likely to benefit from detecting and treating lung cancer at an earlier stage.

Patients should review their eligibility regularly with their healthcare provider, especially when their medical circumstances change.

What If You Have Symptoms of Lung Cancer?

Lung cancer screening is designed for eligible individuals who do not have symptoms.

People experiencing persistent coughing, coughing up blood, unexplained weight loss, chest pain, or worsening shortness of breath may need diagnostic evaluation rather than routine screening.

These symptoms can have several possible causes and do not necessarily indicate lung cancer. However, they should not be ignored.

A pulmonologist can review symptoms, medical history, and risk factors to determine which diagnostic tests may be appropriate.

Lung Cancer Awareness Month: A Reason to Discuss Your Risk

Lung Cancer Awareness Month encourages conversations about prevention, early detection, and the importance of recognizing individual risk factors.

For people with a significant smoking history, one of the most useful steps may be asking a healthcare professional whether annual low-dose CT screening is appropriate.

For current smokers, smoking cessation remains one of the most important ways to reduce future lung cancer risk and protect respiratory health.

Former smokers should also understand that quitting does not immediately eliminate risk and that screening may remain appropriate for a period of time.

Being informed about eligibility and following recommended medical guidance can help patients make more confident decisions about their lung health.

Speak With Pulmonary & Sleep Center of the Valley About Your Lung Health

If you have a history of smoking, concerns about lung cancer risk, or persistent respiratory symptoms, Pulmonary & Sleep Center of the Valley can help evaluate your pulmonary health and discuss appropriate next steps.

The experienced pulmonary care team provides comprehensive respiratory evaluations and personalized care for patients throughout the Rio Grande Valley. When clinically appropriate, your healthcare provider can help determine whether lung cancer screening or additional diagnostic evaluation should be considered.

Contact Pulmonary & Sleep Center of the Valley today to schedule a pulmonary consultation and take an informed step toward protecting your long-term lung health.